http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112410307-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-10022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-10034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18121 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-93 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate | 2020-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112410307-B |
| titleOfInvention | Newcastle disease virus for encoding chicken infectious bursal disease virus VP2Y and application thereof in preparation of biological adjuvant bivalent vaccine |
| abstract | The invention discloses a Newcastle disease virus strain for encoding chicken infectious bursal disease virus VP2Y and application thereof in preparation of a biological adjuvant bivalent vaccine. The Newcastle disease recombinant virus provided by the invention is rClone30-VP2Y-chGM-CSF (P/M), rClone30-VP2Y-IRES-chGM-CSF (P/M) or rClone30-VP2Y (NP) -chGM-CSF (P/M); a protein consisting of VP2Y in the recombinant Newcastle disease virus rClone30-VP2Y-chGM-CSF (P/M), rClone30-VP2Y-IRES-chGM-CSF (P/M) or rClone30-VP2Y (NP) -chGM-CSF (P/M), such as amino acid residues 1 to 195 in the sequence 1; wherein the chGM-CSF is a protein consisting of amino acid residues 1-144 from the N terminal of the sequence 3; the Newcastle disease recombinant virus rClone30-VP2Y-chGM-CSF (P/M), rClone30-VP2Y-IRES-chGM-CSF (P/M) or rClone30-VP2Y (NP) -chGM-CSF (P/M) with different sites has the advantages of inducing an organism to generate antibodies 7 days after immunization, enhancing the immune response of the organism and the like, and opens up a new situation on the prevention history of Newcastle disease and infectious bursal disease of chicken. |
| priorityDate | 2020-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 262.